RHBC
CVS icon

R.H. Bluestein & Co’s CVS Health CVS Stock Holding History

R.H. Bluestein & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$22.8M Buy
239,186
+110,233
+85% +$10.9M 1.42% 20
2022
Q2 		$11.9M Buy
128,953
+7,761
+6% +$757K 0.73% 30
2022
Q1 		$12.3M Buy
+121,192
New +$12.7M 0.51% 39
2020
Q1 		– Sell
-357,828
Closed -$26.6M – 302
2019
Q4 		$26.6M Buy
357,828
+347,863
+3,491% +$24.4M 1.33% 34
2019
Q3 		$628K Buy
+9,965
New +$591K 0.04% 122
2019
Q1 		– Sell
-6,412
Closed -$420K – 301
2018
Q4 		$420K Buy
+6,412
New +$479K 0.03% 128
2018
Q3 		– Sell
-9,691
Closed -$624K – 318
2018
Q2 		$624K Buy
+9,691
New +$639K 0.03% 118
2018
Q1 		– Sell
-3,486
Closed -$253K – 324
2017
Q4 		$253K Buy
+3,486
New +$253K 0.01% 279
2016
Q4 		– Sell
-2,360
Closed -$210K – 310
2016
Q3 		$210K Hold
2,360
– – 0.01% 270
2016
Q2 		$226K Sell
2,360
-201,072
-99% -$20M 0.02% 248
2016
Q1 		$21.1M Sell
203,432
-2,738
-1% -$266K 1.52% 28
2015
Q4 		$20.2M Sell
206,170
-56,991
-22% -$5.58M 1.26% 37
2015
Q3 		$25.4M Buy
+263,161
New +$27.7M 1.8% 31
2014
Q2 		– Sell
-166,383
Closed -$12.5M – 365
2014
Q1 		$12.5M Sell
166,383
-17,715
-10% -$1.25M 0.82% 46
2013
Q4 		$13.2M Buy
184,098
+27,688
+18% +$1.78M 0.83% 46
2013
Q3 		$8.88M Buy
156,410
+20,885
+15% +$1.24M 0.63% 50
2013
Q2 		$7.75M Buy
+135,525
New +$7.85M 0.68% 46

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

R.H. Bluestein & Co's CVS Position: Q3 2022 in Review

R.H. Bluestein & Co increased its CVS Health (CVS) stake by 85% in Q3 2022, buying an estimated $10.9M and bringing the position to 239,186 shares worth $22.8M. The position accounts for 1.42% of the portfolio, ranked #20.

R.H. Bluestein & Co first reported a position in CVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $26.6M in Q4 2019. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • R.H. Bluestein & Co held 239,186 shares of CVS Health worth $22.8M as of Q3 2022.
  • R.H. Bluestein & Co bought 110,233 CVS Health shares in Q3 2022, an estimated $10.9M.
  • CVS Health made up 1.42% of R.H. Bluestein & Co's portfolio in Q3 2022, its #20 holding.
  • R.H. Bluestein & Co first reported a position in CVS Health in Q2 2013 and has held it in 17 quarters since.
  • R.H. Bluestein & Co's CVS Health position peaked at $26.6M in Q4 2019.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.